Zobrazeno 1 - 10 of 37 pro vyhledávání: '"Caroline Duley"'
1
The Importance of Monitoring the Postpartum Period in Moderate to Severe Crohn’s Disease
Autor: Dawn B. Beaulieu, David A. Schwartz, Elizabeth A. Scoville, Kim Annis, Alexander P. Mamunes, Ailish Garrett, Robin Dalal, Caroline Duley, Sara N. Horst, Mindy Kim, Audrey L. Bennett, Julianne H. Wagnon
Publikováno v: Inflammatory Bowel Diseases. 28:409-414
Background Prior research demonstrates Crohn’s disease patients often do well in pregnancy; however, less is known about the risk of flare in the postpartum period. Methods A retrospective chart review was conducted at a tertiary care inflammatory
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a3fe16616cea305b888b17268eccb62
https://doi.org/10.1093/ibd/izab104
Zobrazit plný text záznamu
2
Risk Factors for Medication Nonadherence to Self-Injectable Biologic Therapy in Adult Patients With Inflammatory Bowel Disease
Autor: Jonathan R. Ashton, Caroline Duley, Lawrence S. Gaines, Robin Dalal, Ailish Garrett, Dawn B. Beaulieu, Nisha B Shah, Francesca Raffa, Sara N. Horst, Kim Annis, Jennifer Haydek, Julianne H. Wagnon, Elizabeth A. Scoville, Autumn D Zuckerman, Rochelle Wong, David A. Schwartz, James C. Slaughter
Publikováno v: Inflamm Bowel Dis
Background In inflammatory bowel disease (IBD), including Crohn’s disease (CD) and ulcerative colitis (UC), nonadherence to biologic therapy increases risk of disease flare. The aim of this study was to identify risk factors for nonadherence. Metho
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b07e70de7df779d8fc97c39b64583e21
https://doi.org/10.1093/ibd/izz253
Zobrazit plný text záznamu
3
A Single Center Experience With Long-Term Ustekinumab Use and Reinduction in Patients With Refractory Crohn Disease
Autor: Robin Dalal, Julianne Wagnon, Lauren Evers Carlini, Ailish Garrett, Kim Annis, Sara N. Horst, Audrey Bennett, Elizabeth A. Scoville, Dawn B. Beaulieu, Caroline Duley, David A. Schwartz
Publikováno v: Crohn's & Colitis 360
Background Ustekinumab was approved for moderate and severe Crohn’s disease (CD) in 2016, but little is known about long-term outcomes. Methods A retrospective study evaluated all patients with CD treated with ustekinumab, including patients with r
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f9855de86b5010e8d00a9acea53d4a3a
http://europepmc.org/articles/PMC7067228
Zobrazit plný text záznamu
7
Use of Intravenous Immunoglobulin for Patients with Inflammatory Bowel Disease with Contraindications or Who Are Unresponsive to Conventional Treatments
Autor: Caroline Duley, Kim Annis, Dawn B. Beaulieu, David A. Schwartz, Sara N. Horst, Scott A. Merkley, Anne Nohl
Publikováno v: Inflammatory Bowel Diseases. 21:1854-1859
BACKGROUND Managing patients with IBD who are refractory or have contraindications to standard therapies is challenging. Many will lose response, become intolerant to treatment, or develop infections with contraindication for immunosuppression. There
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6956c987977c5b311d076dcdcd7f4a45
https://doi.org/10.1097/mib.0000000000000456
Zobrazit plný text záznamu
8
Depressive Symptoms Predict Anti-tumor Necrosis Factor Therapy Noncompliance in Patients with Inflammatory Bowel Disease
Autor: Dawn B. Beaulieu, Alexis P. Calloway, Sara N. Horst, Kimberly Annis, Caroline Duley, Robin Dalal, Lawrence S. Gaines, David A. Schwartz, Chris Slaughter
Publikováno v: Digestive diseases and sciences. 62(12)
Noncompliance in use of anti-tumor necrosis factor (anti-TNF) therapy in patients with moderate-to-severe inflammatory bowel disease (IBD) can be a factor in medication failure. Few studies have evaluated the contribution of depressive symptoms to me
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ec70dad023b7d550b633ed0db136038
https://pubmed.ncbi.nlm.nih.gov/29052816
Zobrazit plný text záznamu
9
Treatment with Immunosuppressive Therapy May Improve Depressive Symptoms in Patients with Inflammatory Bowel Disease
Autor: Warren D. Taylor, Julianne H. Wagnon, Anne Nohl, Dawn B. Beaulieu, Sara N. Horst, Michael J. Rosen, Lawrence S. Gaines, Caroline Duley, David A. Schwartz, Andrew Chao
Publikováno v: Digestive Diseases and Sciences. 60:465-470
Recent research suggests a relationship of inflammatory bowel disease (IBD) and depression. Our objective was to evaluate for improvement of depressive symptoms with treatment of IBD using immunosuppressive medications.A retrospective study of consec
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f4959e984a951e5666d0b0ffcd1f15d4
https://doi.org/10.1007/s10620-014-3375-0
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje